Judy BlumstockExecutive Director, Corporate Development
Judith provides financial strategy and in-depth portfolio reporting for TIAP and its technologies and companies under management. She also takes an active role in fundraising and investor relations, and leads a variety of special projects.
Prior to joining TIAP (previously MaRS Innovation), Judith was a principal with Genesys Capital Partners, one of the largest Canadian-based venture-capital firms focused on the life sciences industry. She is also a past director of Insception, Millenium Biologix Corp., Plexagen Diagnostics, and Zelos Therapeutics Inc. Previously, Judith was a partner with Royal Bank Capital Partners Life Sciences Fund and, prior to that, director of Bio/pharmaceutical Research at Drug Royalty Corporation.
Judith received her M.B.A. in finance from Columbia Business School and her B.Sc. in Biology from the University of Toronto.